Cognitive Function and Antioxidants in Schizophrenia Patients
Author Information
Author(s): Li Dan, Huang Yuanyuan, Lu Hongxin, Zhou Sumiao, Feng Shixuan, Li Hehua, Li Xuejing, Guo Yi, Fu Chunlian, Chen Guiying, Ning Yuping, Wu Fengchun, Liu Lianqi
Primary Institution: Guangzhou Medical University
Hypothesis
The study aimed to investigate cognitive function and its influencing factors in Chinese patients with schizophrenia.
Conclusion
Cognitive function was decreased in schizophrenia, closely related to ALB and SOD levels as well as negative clinical symptoms.
Supporting Evidence
- Patients with schizophrenia showed lower cognitive performance compared to healthy controls.
- Negative symptoms were associated with decreased cognitive abilities.
- ALB and SOD levels were independent contributors to cognitive performance.
Takeaway
People with schizophrenia have trouble thinking clearly, and this might be linked to certain substances in their blood that help fight damage in the body.
Methodology
The study included 133 patients with schizophrenia and 120 healthy controls, using cognitive assessments and measuring antioxidant levels.
Potential Biases
Potential biases from participant selection and uncontrolled dietary influences.
Limitations
The study's cross-sectional design limits the ability to establish causation, and it only included stable schizophrenia patients.
Participant Demographics
Participants were Han Chinese individuals aged 18 to 60, with no history of psychiatric disorders.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website